SUPPLEMENT

Q4 2024 — Income statement trends

Q4 2024PDF · 2 pages144 KB
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q422 	Q123 	Q223 	Q323 	Q423 	Q124 	Q224 	Q324 	Q424
Revenues:
Clearing and transaction fees 	981.4 	1,200.2 	1,118.3 	1,085.5 	1,184.5 	1,208.9 	1,249.9 	1,297.1 	1,232.3
Market data and information services 	153.2 	165.8 	163.1 	167.6 	167.2 	175.4 	175.0 	178.2 	181.6
Other Revenue 	73.2 	75.6 	78.8 	84.7 	87.6 	103.6 	107.6 	109.1 	111.4
Total revenues 	1,207.8 	1,441.6 	1,360.2 	1,337.8 	1,439.3 	1,487.9 	1,532.5 	1,584.4 	1,525.3
Expenses:
Compensation and benefits 	193.0 	204.5 	205.7 	205.5 	212.9 	206.0 	204.7 	218.8 	220.8
Technology 	50.0 	51.3 	53.3 	55.6 	58.5 	59.4 	64.1 	66.6 	65.7
Professional fees and outside services 	38.5 	38.3 	37.8 	32.2 	36.1 	33.1 	34.7 	31.0 	33.9
Amortization of purchased intangibles 	56.7 	56.8 	57.0 	57.2 	55.6 	55.2 	55.5 	55.7 	55.3
Depreciation and amortization 	33.9 	31.9 	32.3 	31.1 	30.7 	30.1 	28.7 	28.2 	28.1
Licensing and other fee agreements 	72.4 	84.7 	78.2 	79.5 	80.4 	87.9 	85.9 	97.6 	84.0
Other expense 	95.0 	60.4 	57.3 	56.5 	101.9 	56.6 	58.3 	62.3 	90.4
Operating expenses 	539.5 	527.9 	521.6 	517.6 	576.1 	528.3 	531.9 	560.2 	578.2
Operating Income 	668.3 	913.7 	838.6 	820.2 	863.2 	959.6 	1,000.6 	1,024.2 	947.1
Operating Margin 	55% 	63% 	62% 	61% 	60% 	64% 	65% 	65% 	62%
Non-operating Income and Expense
Investment income 	1,152.2 	1,357.7 	1,568.2 	1,272.5 	1,076.9 	1,071.3 	1,044.5 	1,026.8 	936.5
Interest and other borrowing costs 	(39.9) 	(39.9) 	(40.2) 	(39.6) 	(39.7) 	(39.9) 	(40.1) 	(40.2) 	(40.7)
Equity in net gains (losses) of unconsolidated subsidiaries 	64.0 	78.2 	75.1 	76.8 	66.8 	87.2 	86.4 	86.1 	91.2
Other non-operating income (expense) 	(1,017.3) 	(1,152.8) 	(1,425.3) 	(1,155.6) 	(961.2) 	(964.8) 	(936.9) 	(920.0) 	(837.5)
Non-operating income (expense) 	159.0 	243.2 	177.8 	154.1 	142.8 	153.8 	153.9 	152.7 	149.5
Income before income taxes 	827.3 	1,156.9 	1,016.4 	974.3 	1,006.0 	1,113.4 	1,154.5 	1,176.9 	1,096.6
Income taxes 	189.4 	273.1 	238.8 	224.1 	191.4 	258.2 	271.3 	264.1 	222.0
Net income 	637.9 	883.8 	777.6 	750.2 	814.6 	855.2 	883.2 	912.8 	874.6
Less: net income (loss) attributable to NCI 	- 	- 	- 	- 	- 	- 	- 	- 	-
Net Income Attributable to CME Group 	637.9 	883.8 	777.6 	750.2 	814.6 	855.2 	883.2 	912.8 	874.6
Net Income Attributable to Common Shareholders of CME Group 	629.9 	872.7 	767.8 	740.8 	804.3 	844.4 	872.1 	901.3 	863.7
Effective Tax Rate 	22.8% 	23.6% 	23.5% 	23.0% 	19.0% 	23.2% 	23.2% 	22.4% 	20.2%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	1.76 	2.43 	2.14 	2.06 	2.24 	2.35 	2.43 	2.51 	2.40
Diluted EPS 	1.75 	2.43 	2.14 	2.06 	2.24 	2.35 	2.42 	2.50 	2.40
Weighted average number of common stock shares:
Basic Shares 	358,885 	358,933 	358,940 	359,020 	359,197 	359,258 	359,330 	359,400 	359,568
Diluted Shares 	359,190 	359,313 	359,429 	359,619 	359,693 	359,833 	359,869 	359,989 	360,050
Preferred Shares 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584

-- 1 of 2 --

CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NON-GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q422 	Q123 	Q223 	Q323 	Q423 	Q124 	Q224 	Q324 	Q424
Revenues:
Clearing and transaction fees 	981.4 	1,200.2 	1,118.3 	1,085.5 	1,184.5 	1,208.9 	1,249.9 	1,297.1 	1,232.3
Market data and information services 	153.2 	165.8 	163.1 	167.6 	167.2 	175.4 	175.0 	178.2 	181.6
Other Revenue 	73.2 	75.6 	78.8 	84.7 	87.6 	103.6 	106.6 	109.2 	111.3
Total revenues 	1,207.8 	1,441.6 	1,360.2 	1,337.8 	1,439.3 	1,487.9 	1,531.5 	1,584.5 	1,525.2
Expenses:
Compensation and benefits 	184.6 	192.8 	194.4 	193.5 	204.4 	196.1 	201.7 	207.5 	218.9
Technology 	50.0 	51.3 	53.3 	55.6 	58.5 	59.4 	64.1 	66.6 	65.7
Professional fees and outside services 	38.5 	38.3 	37.8 	32.2 	36.1 	33.1 	34.7 	31.0 	33.9
Amortization of purchased intangibles 	- 	- 	- 	- 	- 	- 	- 	- 	-
Depreciation and amortization 	33.9 	31.9 	31.8 	31.1 	29.8 	29.3 	28.7 	28.2 	28.0
Licensing and other fee agreements 	72.4 	84.7 	78.2 	79.5 	80.4 	87.9 	85.9 	97.6 	84.0
Other expense 	84.5 	59.7 	56.2 	56.5 	80.3 	56.5 	58.6 	57.9 	89.7
Operating expenses 	463.9 	458.7 	451.7 	448.4 	489.5 	462.3 	473.7 	488.8 	520.2
Operating Income 	743.9 	982.9 	908.5 	889.4 	949.8 	1,025.6 	1,057.8 	1,095.7 	1,005.0
Operating Margin 	62% 	68% 	67% 	66% 	66% 	69% 	69% 	69% 	66%
Non-operating Income and Expense
Investment income 	1,147.1 	1,277.5 	1,564.0 	1,276.6 	1,068.5 	1,061.7 	1,033.0 	1,022.3 	943.8
Interest and other borrowing costs 	(39.9) 	(39.9) 	(40.2) 	(39.6) 	(39.7) 	(39.9) 	(40.1) 	(40.2) 	(40.7)
Equity in net gains (losses) of unconsolidated subsidiaries 	76.2 	91.5 	88.6 	90.4 	85.1 	100.7 	98.8 	99.7 	104.8
Other non-operating income (expense) 	(1,023.3) 	(1,160.6) 	(1,429.9) 	(1,157.1) 	(958.8) 	(964.8) 	(936.9) 	(920.0) 	(837.5)
Non-operating income (expense) 	160.1 	168.5 	182.5 	170.3 	155.1 	157.7 	154.8 	161.8 	170.4
Income before income taxes 	904.0 	1,151.4 	1,091.0 	1,059.7 	1,104.9 	1,183.3 	1,212.6 	1,257.5 	1,175.4
Income taxes 	206.0 	269.1 	254.6 	241.7 	240.2 	272.2 	280.4 	280.5 	256.5
Net income 	698.0 	882.3 	836.4 	818.0 	864.7 	911.1 	932.2 	977.0 	918.9
Less: net income (loss) attributable to NCI 	- 	- 	- 	- 	- 	- 	- 	- 	-
Net Income Attributable to CME Group 	698.0 	882.3 	836.4 	818.0 	864.7 	911.1 	932.2 	977.0 	918.9
Net Income Attributable to Common Shareholders of CME Group 	689.1 	871.1 	825.9 	807.8 	853.8 	899.7 	920.4 	964.7 	907.4
Effective Tax Rate 	22.8% 	23.4% 	23.3% 	22.8% 	21.7% 	23.0% 	23.1% 	22.3% 	21.8%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	1.92 	2.43 	2.30 	2.25 	2.38 	2.50 	2.56 	2.68 	2.52
Diluted EPS 	1.92 	2.42 	2.30 	2.25 	2.37 	2.50 	2.56 	2.68 	2.52
Weighted average number of common stock shares:
Basic Shares 	358,885 	358,933 	358,940 	359,020 	359,197 	359,258 	359,330 	359,400 	359,568
Diluted Shares 	359,190 	359,313 	359,429 	359,619 	359,693 	359,833 	359,869 	359,989 	360,050
Preferred Shares 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584

-- 2 of 2 --